Categories
Local

U.S. FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/

(Reuters) – The U.S. Food and Drug Administration on Saturday issued an emergency use authorization for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease.

Reporting by Rama Venkat and Manas Mishra in Bengaluru; Editing by Dan Grebler

https://static.reuters.com/resources/r/?m=02&d=20201122&t=2&i=1542035130&r=LYNXMPEGAL00Q&w=800

Source: Reuters

Leave a Reply

Your email address will not be published. Required fields are marked *